ArticleFrontiers in oncology2025

Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database.

Huiling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.